The ability of an electronic infusion controller (IVAC 230) to reduce morbidity in peripheral intravenous infusions was investigated in a controlled randomized trial. The results were assessed on the number of sites of injection in relation to the total duration of perfusion, with an adjustment for the quality of the fluids infused. Using the controller resulted in a 50% decrease in the number of sites of injection (risk alpha = 1%, beta = 10%).
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!